Deferoxamine

{
  "id": "MLC-T-ONC-002331",
  "term": "Deferoxamine",
  "field": "Oncology and biomedicine",
  "definitions": [
    "An iron-chelating agent that removes iron from tumors by inhibiting DNA synthesis and causing cancer cell death. It is used in conjunction with other anticancer agents in pediatric neuroblastoma therapy.",
    "An iron-chelating agent that binds free iron in a stable complex, preventing it from engaging in chemical reactions. Deferoxamine chelates iron from intra-lysosomal ferritin and siderin forming ferrioxamine, a water-soluble chelate excreted by the kidneys and in the feces via the bile. This agent does not readily bind iron from transferrin, hemoglobin, myoglobin or cytochrome."
  ],
  "abbreviation": "DFO-B",
  "synonyms": [
    "desferoxamine B",
    "desferrioxamine",
    "desferrioxamine B"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms",
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/deferoxamine/"
}